IXICO says full year will be ahead of market expectations
21st Aug 2018 07:56
(Sharecast News) - Data science company IXICO said on Tuesday that trading for the year to 30 September is now expected to be ahead of market expectations.
Read moreIXICO expands contract with top 10 pharmaceutical company
13th Aug 2018 08:03
(Sharecast News) - AIM-listed data science company IXICO has signed an expanded scope to a current contract with a top 10 pharmaceutical company three months into the contract.
Read moreGiulio Cerroni appointed CEO of IXICO
17th Jan 2017 08:47
(ShareCast News) - Brain health company IXICO announced on Tuesday that Giulio Cerroni will be appointed to the board as chief executive officer, with effect from 6 February. The AIM-traded firm said Derek Hill, the co-founder and current CEO, will remain on the board and continue to serve as an exe
Read moreIxico joins European syndicate to collect data on Alzheimer's
16th Nov 2016 10:01
(ShareCast News) - Brain health company Ixico is to receive €100,000 to provide digital technologies for collection and analysis of data , which further expands its work on wearable bio-sensors as part of a pan-European partnership. The AIM-listed company is to participate in a new collaborative EU
Read moreIxico's income falls slightly but has a number of contracts in the pipeline
21st Oct 2016 10:15
(ShareCast News) - AIM-listed Ixico's income for the year fell, but the brain health company has a number of contracts with pharmaceuticals in the pipeline and a "strong" balance sheet. In trading update for the year ended 30 September, the company reported revenues of £3.1m and other income of £700
Read moreIxico pens deal to help develop a therapy for Parkinson's like diesease
20th Oct 2016 11:01
(ShareCast News) - Shares in AIM-listed Ixico rose above 22% on Thursday, as the brain health company announced it had signed a $1.2m contract with a global pharmaceutical for imaging clinical trial services for a Parkinson's-like neurodegenerative disease. The project is for a second phase clinical
Read moreIxico to receive €1m from EU Alzheimer's project
10th Oct 2016 12:26
(ShareCast News) - AIM-listed pharmaceutical Ixico is to receive €1m as a partner in an EU public-private consortium, which has the potential for long-term revenue through the development of diagnostic and disease management technologies for Alzheimer's. Ixico is to work on the Amyloid Imaging to Pr
Read moreIXICO study joins Dementias Platform
2nd Jun 2016 16:27
(ShareCast News) - Brain health company IXICO announced on Thursday that its Cygnus study has joined the high-profile Dementias Platform UK (DPUK). The AIM-traded firm described Cygnus as a real-world digital data collection study from people with cognitive impairment and dementia. It said the four
Read moreIxico wins four new contracts worth over £3m
18th Jan 2016 13:51
(ShareCast News) - Brain health company Ixico was recently awarded four new contracts with "leading" pharmaceutical groups and a specialist biotechnology firm totalling over £3m in value. The contracts involve global clinical trials of novel drugs for Alzheimer's disease spanning three major phases
Read moreIxico full-year income in line with expectations
19th Oct 2015 12:33
(ShareCast News) - Brain health company Ixico reported revenues for the year of £3.1m and other income at £1m, in line with market expectations and giving a total combined income of £4.1m. This was down from £4.3m for the 16-month period to 30 September 2014. In a pre-close trading update ahead of
Read moreIxico secures two clinical trial contracts alongside partner VirtualScopics
29th Jun 2015 11:11
Ixico has won two contracts to deploy its products in unnamed pharmaceutical companies' clinical trials, alongside its partner VirtualScopics. Both studies will employ Ixico's TrialTracker digital platform to collect and image data, one pertaining to metastatic solid tumours and the other to rare ne
Read moreIxico partners with the Medical Research Council to launch UK Dementias Research Platform
19th Jun 2014 08:30
Biotechnology group Ixico has partnered with the Medical Research Council (MRC) to launch the UK Dementias Research Platform (UKDP), a £16m public-private partnership. The group, which set up the partnership to speed up research into dementias, will act as the MRC's imaging partner on the project a
Read moreThursday broker round-up UPDATE
20th Mar 2014 09:19
Antofagasta: Deutsche Bank cuts target price from 770p to 735p and downgrades to sell. Investec cuts target price from 753p to 726p keeping its sell recommendation. Ashmore Group: HSBC Holdings lowers target price from 410p to 400p retaining its overweight rating. Avacta Group: Numis shifts target
Read moreStandard Chartered non-exec builds company holding after profit decline
11th Mar 2014 15:45
An Independent Non-Executive Director of Standard Chartered has this week upped his stake in the group by a quarter with the purchase of 2,500 shares. John Paynter, who was appointed to his role in 2008, bought the shares at 1,246.50p each for a total of £31,163, taking his total holding to 12,50
Read more